Literature DB >> 22392265

Selective arterial embolization of giant renal tuberous sclerosis.

Valentina De Pasquale1, Gianluigi Natali, Piergiorgio Falappa, Simona Gerocarni Nappo, Annamaria Salerno, Paolo Caione.   

Abstract

Different minimally invasive methods have been proposed to treat renal manifestation of tuberous sclerosis complex (TSC), in order to preserve kidney parenchyma and avoid nephrectomy. The case of a boy with bleeding giant angiomyolipoma treated by selective arterial embolization is discussed. The extensive renal lesions resulted significantly decreased, with resolution of arterial hypertension and abdominal symptoms. Differential renal function increased from 26.6% to 32.6%. Renal involvement in TSC requires careful parenchymal-sparing procedures. Selective embolization of the main renal lesions should be considered as first line therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22392265     DOI: 10.1007/s12098-012-0716-x

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms.

Authors:  Raouf M Seyam; Nabil K Bissada; Said A Kattan; Alaa A Mokhtar; Muhammad Aslam; Wahib E Fahmy; Walid A Mourad; Ali A Binmahfouz; Hassan M Alzahrani; Kamal A Hanash
Journal:  Urology       Date:  2008-09-21       Impact factor: 2.649

Review 2.  Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies.

Authors:  Tobias Klatte; Bernhard Grubmüller; Matthias Waldert; Peter Weibl; Mesut Remzi
Journal:  Eur Urol       Date:  2011-05-17       Impact factor: 20.096

3.  The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma.

Authors:  Chi Kwok Chan; Simon Yu; Sidney Yip; Paul Lee
Journal:  Urology       Date:  2010-12-04       Impact factor: 2.649

Review 4.  Clinical and molecular insights into tuberous sclerosis complex renal disease.

Authors:  Brian J Siroky; Hong Yin; John J Bissler
Journal:  Pediatr Nephrol       Date:  2010-12-09       Impact factor: 3.714

Review 5.  Tuberous sclerosis complex: neurological, renal and pulmonary manifestations.

Authors:  D N Franz; J J Bissler; F X McCormack
Journal:  Neuropediatrics       Date:  2011-01-05       Impact factor: 1.947

6.  Retroperitoneal laparoscopic nephron-sparing surgery for renal tumors: report of 32 cases.

Authors:  Xu Zhang; Hong-Zhao Li; Xin Ma; Tao Zheng; Long-Cheng Li; Zhang-Qun Ye
Journal:  Urology       Date:  2005-06       Impact factor: 2.649

7.  Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex.

Authors:  Ramón Peces; Carlos Peces; Emilio Cuesta-López; Virginia Pérez-Dueñas; Cristina Vega-Cabrera; Sebastián Azorín; Rafael Selgas
Journal:  Nephrol Dial Transplant       Date:  2010-07-27       Impact factor: 5.992

8.  Renal lesion growth in children with tuberous sclerosis complex.

Authors:  D H Ewalt; E Sheffield; S P Sparagana; M R Delgado; E S Roach
Journal:  J Urol       Date:  1998-07       Impact factor: 7.450

Review 9.  Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria.

Authors:  E S Roach; M R Gomez; H Northrup
Journal:  J Child Neurol       Date:  1998-12       Impact factor: 1.987

Review 10.  Contemporary diagnosis and management of renal angiomyolipoma.

Authors:  Caleb P Nelson; Martin G Sanda
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

  10 in total
  1 in total

Review 1.  Tuberous sclerosis complex: new insights into clinical and therapeutic approach.

Authors:  Angela Volpi; Gabriele Sala; Elena Lesma; Francesca Labriola; Marco Righetti; Rosa Maria Alfano; Mario Cozzolino
Journal:  J Nephrol       Date:  2018-11-07       Impact factor: 3.902

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.